Status:
UNKNOWN
CH-EUS in Diagnosis of Inoperable Bile Duct Tumors
Lead Sponsor:
Institutul Regional de Gastroenterologie & Hepatologie Prof. dr. Octavian Fodor
Conditions:
Inoperable Disease
Bile Duct Cancer
Eligibility:
All Genders
18-99 years
Phase:
NA
Brief Summary
VALIDATION OF THE SUPERIORITY OF CONTRAST ENHANCED ENDOSCOPY TO STANDARD ENDOSCOPY IN THE DIAGNOSIS OF BILE DUCT TUMORS
Eligibility Criteria
Inclusion
- Bile duct tumor diagnosed at endoscopic US, CT scan or MRI
- INR\<1.5; platelets \> 50.000
- written consent form
Exclusion
- INR\>1.5; platelets \< 50.000
- duodenal invasion or stenosis
- patients denial
- previous treatment for hepato-biliary tumors
Key Trial Info
Start Date :
January 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 30 2022
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT05418543
Start Date
January 1 2022
End Date
December 30 2022
Last Update
June 15 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
IRGH "O. Fodor"
Cluj-Napoca, Cluj, Romania, 400394